Emanuele Ammatuna Selected Research

Emanuele Ammatuna Research Topics

Disease

13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2023 - 11/2005
11	Neoplasms (Cancer) 12/2023 - 03/2005
9	Leukemia 12/2023 - 11/2007
7	COVID-19 01/2024 - 11/2022
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2018
5	Lymphoma (Lymphomas) 03/2024 - 01/2004
5	Acute Promyelocytic Leukemia 10/2020 - 01/2006
3	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 11/2022
3	Infections 11/2023 - 01/2004
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2010 - 02/2002
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 02/2008
2	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 06/2015 - 05/2015
2	Multiple Sclerosis 07/2009 - 03/2009
1	Pemphigus (Pemphigus Vulgaris) 03/2024
1	Lymphopenia (Lymphocytopenia) 12/2023
1	Stomatitis 11/2023
1	Anosmia 04/2023
1	Lung Diseases (Lung Disease) 04/2023
1	Fever (Fevers) 04/2023
1	Sinusitis 04/2023
1	Rhinitis 04/2023
1	Obesity 04/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Necrosis 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2019
1	Pneumonia (Pneumonitis) 01/2014
1	Disease Progression 12/2010
1	Residual Neoplasm 10/2008
1	Genetic Translocation (Chromosomal Translocation) 11/2007
1	Polycythemia (Erythrocytosis) 05/2007
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 05/2007
1	Thrombocytosis (Thrombocythemia) 05/2007
1	Cytopenia 08/2005
1	Hypersplenism (Anemia, Splenic) 08/2005
1	Hepatitis 03/2005
1	Hepatitis B 03/2005

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2007
6	Rituximab (Mabthera)FDA Link 03/2024 - 01/2018
5	Arsenic Trioxide (Trisenox)FDA Link 01/2022 - 08/2008
4	VaccinesIBA 12/2023 - 11/2022
4	Monoclonal AntibodiesIBA 12/2022 - 02/2002
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 01/2006
3	NucleophosminIBA 09/2010 - 11/2005
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 10/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2019 - 10/2019
2	Vincristine (Oncovin)FDA LinkGeneric 11/2019 - 10/2019
2	AntibodiesIBA 01/2019 - 01/2018
2	ruxolitinibIBA 06/2015 - 05/2015
2	Janus Kinase InhibitorsIBA 06/2015 - 05/2015
2	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2009 - 03/2009
2	Alemtuzumab (Campath)FDA Link 05/2009 - 03/2005
1	AutoantibodiesIBA 03/2024
1	Desmoglein 3IBA 03/2024
1	Desmoglein 1IBA 03/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	Decitabine FDA Link 11/2023
1	Carrier Proteins (Binding Protein)IBA 07/2023
1	Polysaccharides (Glycans)IBA 07/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2023
1	nirmatrelvir and ritonavir drug combinationIBA 04/2023
1	tixagevimabIBA 01/2023
1	cilgavimabIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	ProteomeIBA 11/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	Estrogen Receptor betaIBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 11/2019
1	Prednisone (Sone)FDA LinkGeneric 10/2019
1	Cladribine FDA LinkGeneric 01/2014
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 12/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2010
1	Mutant Proteins (Protein, Mutant)IBA 09/2010
1	trioctyl phosphine oxide (TOPO)IBA 03/2009
1	DNA (Deoxyribonucleic Acid)IBA 03/2009
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2009
1	polyacrylamideIBA 01/2009
1	Retinoic Acid Receptor alphaIBA 08/2008
1	AnthracyclinesIBA 08/2008
1	L-SelectinIBA 02/2008
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2008
1	Transcription Factors (Transcription Factor)IBA 11/2007
1	MicroRNAs (MicroRNA)IBA 11/2007
1	Genetic Markers (Genetic Marker)IBA 05/2007
1	Glutathione (Reduced Glutathione)IBA 03/2006
1	Glutamate-Cysteine LigaseIBA 03/2006
1	Gemtuzumab (Mylotarg)FDA Link 01/2006
1	Pentostatin (Nipent)FDA LinkGeneric 08/2005
1	Lamivudine (Epivir)FDA Link 03/2005
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2005

Therapy/Procedure

14	Therapeutics 03/2024 - 01/2004
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2004
2	Immunotherapy 01/2019 - 03/2005
2	Aftercare (After-Treatment) 07/2009 - 03/2009
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Radiotherapy 01/2020
1	Splenectomy 08/2005